Skip to main content

Research

Publications

Recent peer-reviewed publications by Hussein Yassine, MD from PubMed (opens in new tab).

View all on PubMed (81+ results) (opens in new tab)
Clinical Trial2026

CNS target engagement of high-dose DHA supplementation in older adults at risk for dementia: a randomised, double-blind, placebo-controlled trial.

EBioMedicine

Yassine HN, et al.

PMID: 42315445 →

(opens in new tab)
Journal Article2026

Apolipoprotein E4 as a Modifier of Chemotherapy Response.

Am J Pathol

Yassine HN

PMID: 42362019 →

(opens in new tab)
Journal Article2026

TOMM40 suppression promotes neuronal cholesterol imbalance and molecular and behavioral phenotypes of Alzheimer's disease.

Alzheimers Dement

Yang NV, et al.

PMID: 41954048 →

(opens in new tab)
Review2026

A perspective: PLA2G4A as drug target for vascular inflammation in Alzheimer's disease.

Alzheimers Dement

Kanwal A, et al.

PMID: 41950067 →

(opens in new tab)
Journal Article2026

α-Linolenic acid-rich diet boosts docosahexaenoic acid levels and restores lipid balance in the brain parenchyma and vasculature of APOE4 mice.

J Nutr Biochem

Leikin-Frenkel A, et al.

PMID: 41887535 →

(opens in new tab)
Journal Article2026

Elevated levels of circulating plasma sPDGFRβ in cognitively impaired APOE4 carriers.

Geroscience

Sagare AP, et al.

PMID: 42118474 →

(opens in new tab)
Journal Article2026

Evidence for cPLA2 activation in Alzheimer's disease synaptic pathology.

Acta Neuropathol Commun

Ma QL, et al.

PMID: 41680938 →

(opens in new tab)
Journal Article2026

Development of potent, selective cPLA2 inhibitors for targeting neuroinflammation in Alzheimer's disease and other neurodegenerative disorders.

NPJ Drug Discov

Sadybekov AV, et al.

PMID: 41523267 →

(opens in new tab)
Review2025

APOE-Targeted Therapeutics for Alzheimer's Disease.

J Neurosci

Yassine HN, et al.

PMID: 41224653 →

(opens in new tab)
Journal Article2025

Increased cerebrospinal fluid and plasma apoE glycosylation is associated with reduced levels of Alzheimer's disease biomarkers.

Alzheimers Res Ther

Yassine HN, et al.

PMID: 40635030 →

(opens in new tab)
Journal Article2025

High precision and cost-effective multiplex quantification of amyloid-β40, amyloid-β42, p181Tau, p217Tau, neurofilament light chain, and glial fibrillary acidic protein from plasma and serum.

J Alzheimers Dis

Yassine HN, et al.

PMID: 40356374 →

(opens in new tab)
Journal Article2025

Sex specific associations of sex hormones with brain volumes and cerebral blood flow: A cross sectional observational study within the look AHEAD type 2 diabetes cohort.

J Diabetes Complications

Yassine HN, et al.

PMID: 40886675 →

(opens in new tab)

Data sourced from pubmed.ncbi.nlm.nih.gov (opens in new tab). Search: Yassine HN [Author] · Alzheimer's / APOE / dementia.